Get on the path to results today.
FosterAtLaw™
Arbitration
ARBITRATION
Having adjudicated over 200 disputes, the Firm’s ADR capabilities run the gamut from resolution of domestic and international infringement cases to settlement of multinational commercial disputes including arbitration, mock trials, fact-finding, discovery referee and special master.
The Firm routinely serves privately as an arbitrator for various commercial, financial and intellectual property matters, and as neutral for the American Arbitration Association (AAA), International Centre for Dispute Resolution (ICDR), the Institute for Conflict Resolution & Prevention (CPR), the World Intellectual Property Organization (WIPO), the International Chamber of Commerce (ICC), and the Financial Industry Regulatory Authority (FINRA). The Firm moves easily between litigation, arbitration and mediation matching our courtroom capabilities with exceptional ADR skills.
The following is a selective sampling of matters arbitrated:
- International dispute in connection with joint development agreement involving chemical process
- Dispute involving international parties regarding a medical device license.
- International patent license dispute involving overpayment of past royalties.
- Dispute involving payment of future royalties in chemical-related patent.
- Dispute concerning determination of license royalties in biotechnology invention.
- Licensing dispute involving an adhesion clause with dispute whether chemical technology in question was included in the adhesion contract.
- Licensing and sale agreement dispute involving over-the-counter drugs; breach of sales agreement involving medical device.
- Licensing agreement dispute involving pharmaceutical drugs.
- Licensing disputes involving chemical products.
- Breach of contract disputes whether by-product of a pharmaceutical drug feel under the terms of contract.
- Patent infringement case involving whether pharmaceutical drugs were included in license agreement.
- License agreement involving whether later discovered/developed IT technology was within the scope of the agreement.
- Trade secret agreement breach involving healthcare IT technology.
- Product development and consulting agreement involving whether biotechnology techniques were included in agreement.
- License agreement breach involving whether royalties were warranted in biochemical sublicense agreement.
- Dispute involving patent infringement of patents for chemical products.
- Dispute involving international patent license for agricultural pharmaceuticals.
- Dispute involving patent infringement of patent for biotechnology byproducts.
- Contractual dispute between health plan and pharmacy benefit management plan.
- Dispute involving license agreement regarding pharmaceutical products involved in vaccine process and formulation.
- Dispute involving trade secret misappropriation and patent infringement.
- Dispute involving breach of collaboration, supply and distribution agreement regarding manufacturing and commercialization of an active pharmaceutical ingredient.